Highlight Therapeutics
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Highlight Therapeutics has raised €38M across 2 funding rounds from 2 investors, most recently a round in Sep 2025. Based in Paterna, Spain; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€38M
€37,600,000
Funding rounds
2
Investors
2
distinct backers
Active since
2021-02
latest 2025-09
Funding by year
EUR raised per yearHighlight Therapeutics — funding by year — interactive chart.
Data table
| Highlight Therapeutics — funding by year | |
|---|---|
| 2021 | €23M |
| 2025 | €15M |
Signals
High confidenceRaise-next likelihood36
base rate 30% for Other
- ▲ In typical raise window
- ▼ Down/flat last round
- ▼ Low backer re-investment
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▼ Old (16y) — past typical exit age
- ▲ Recent equity round, but funding momentum is down (may be rescue financing)
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-09-16 | Other | €15M | Buenavista Equity Partners,Columbus Venture Partners | View deal → |
| 2021-02-04 | Other | €23M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData